Radiohalogenated half-antibodies and maleimide intermediate ther

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548549, C07D20727, A61K 3700

Patent

active

049945572

ABSTRACT:
N-(m-radiohalophenyl) maleimide can be conjugated with a reduced antibody having a mercapto group to provide a radiolabelled half-antibody having immunological specific binding characteristics of whole antibody.

REFERENCES:
patent: 4111937 (1978-09-01), Ackerman
patent: 4207308 (1980-06-01), Spenney
patent: 4735792 (1988-04-01), Srivestava
Design and Synthesis of a New N-[p-.sup.125 I]-Iodophenyl)-Maleimide ([.sup.125 I]IPM) "KIT" for Labeling of Antibodies with .sup.131 I and .sup.123 I-P. C. Srivastava et al., J. Nuclear Medicine, vol. 28, 726 (No. 717) (1987).
European Patent Application Publication EP No. 0203764 A2-Wilbur et al., Radiohalogenated Small Molecules for Protein Labeling, (Published Dec. 3, 1986).
Method for Radiohalogenation of Proteins Resulting in Decreased Thyroid Uptake of Radioiodine, Zalutsky et al., Appl. Radiat. Isotopes, vol. 38, No. 12, 1051-1055 (1987).
An Improved Method for the Radiohalogenation of Monoclonal Antibodies, Zalutsky et al., from: Immunological Approaches to the Diagnosis and Therapy of Breast Cancer, Edited by Roberto L. Ceriani (Plenum Publishing Corp., 1987).
N-(p-Iodophenyl) Maleimide, A New Radioiodinated Thiol Reagent With Selective Effects on Platelet Membrane Functions-P. C. Srivastava et al., J. Nuclear Medicine, vol. 27, 1046 (No. 697) (1986).
Synthesis and Radioiodination of Iodophenyl Conjugates for Protein Labeling M. Hylarides et al., J. Nuclear Medicine, vol. 28, 560 (No. 14) (1987).
Evaluation of Radioiodinations and Conjugations of 4-Iodobenzoates for Protein labeling-S. W. Hadley et al., J. Nuclear Medicine, vol. 28, 725 (No. 712) (1987).
Method for Radiohalogenation of Proteins Resulting in Increased Retention of Label In Vivo-A. S. Narula et al., J. Nuclear Medicine, vol. 28, 725 (No. 715) (1987).
Radioiodination of Monoclonal Antibodies Labeling with Para-Iodophenyl (PIP) Derivatives for In Vivo Stability of the Radioiodine Label-D. S. Wilbur et al., J. Nuclear Medicine, vol. 27, 959 (No. 335) (1986).
Synthesis and Radioiodinations of Some Aryltin Compounds for Radiolabeling of Monoclonal Antibodies, D. S. Wilbur et al.,-Poster from Sixth International Symposium on Radiopharmaceutical Chemistry, Boston, Jun. 1986.
Evaluation of Radioiodinated Monoclonal Antibody Conjugates which are Resistant to In Vivo Deiodination-S. Wilbur et al.-Poster and Abstract from Second International Conf. on Monoclonal Antibody Immunoconjugates for Cancer, Mar. 1987.
Layne et al., J. of Immunological Methods, vol. 96, pp. 195-199 (1987).
Wursthorn et al., J. Organometallic Chem., vol. 140 pp. 29-39 (1977).
Brennan et al., Science, vol. 229, 81-83 (1985).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Radiohalogenated half-antibodies and maleimide intermediate ther does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiohalogenated half-antibodies and maleimide intermediate ther, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiohalogenated half-antibodies and maleimide intermediate ther will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1144743

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.